Download PDF
Zeitschrift für Orthomolekulare Medizin 2025; 23(01): 22-29
DOI: 10.1055/a-2546-7308
Wissen

Bedeutung von NAD für Vitalität, Alterung und Langlebigkeit

Stephan Sudowe
› Further Information
   Permissions and Reprints

Zusammenfassung

Nicotinamid-Adenin-Dinukleotid (NAD) spielt als essenzielles Coenzym eine zentrale Rolle im zellulären Energiestoffwechsel. Darüber hinaus beeinflusst und steuert NAD weitere physiologische Prozesse, die für Gesundheit, Vitalität und eine hohe Langlebigkeit (Longevity) maßgeblich sind. Die Bestimmung der NAD-Spiegel kann für die individualisierte Diagnostik metabolischer, immunologischer oder mitochondrialer Dysfunktionen äußerst hilfreich sein und die Basis für die Erstellung personalisierter Therapiekonzepte darstellen.

Schlüsselwörter

NAD+ - NADH - Mitochondrien - ATP-Synthese - Sirtuine - Longevity - Seneszenz - NAD-Mangel - NAD-Biosynthese


Publication History

Article published online:
22 April 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Gröber U. NAD+ – ein alter Bekannter aus den Anfängen der Orthomolekularen Medizin. Zs f Orthomol Med 2023; 21: 36-41
    Thieme ConnectSearch in Google Scholar
  • 2 Alemasova EE, Lavrik OI. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins. Nucleic Acids Res 2019; 47: 3811-3827
    PubMedSearch in Google Scholar
  • 3 Murata MM. et al. NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival. Mol Biol Cell 2019; 30: 2584-2597
    PubMedSearch in Google Scholar
  • 4 Gupte R. et al. PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes. Genes Dev 2017; 31: 101-126
    PubMedSearch in Google Scholar
  • 5 Wu QJ. et al. The sirtuin family in health and disease. Signal Transduct Target Ther 2022; 7: 402
    PubMedSearch in Google Scholar
  • 6 Hsu WW. et al. Sirtuins 1 and 2 are universal histone deacetylases. ACS Chem Biol 2016; 11: 792-799
    PubMedSearch in Google Scholar
  • 7 Michan S. Calorie restriction and NAD+/sirtuin counteract the hallmarks of aging. Front Biosci (Landmark Ed) 2014; 19: 1300-1319
    PubMedSearch in Google Scholar
  • 8 Poljsak B. et al. Healthy lifestyle recommendations: do the beneficial effects originate from NAD+ amount at the cellular level?. Oxid Med Cell Longev 2020; 2020: 8819627
    PubMedSearch in Google Scholar
  • 9 Zhou S. et al. Sirtuins and insulin resistance. Front Endocrinol 2018; 9: 748
    Search in Google Scholar
  • 10 Gámez-García A, Vazquez BN. Nuclear sirtuins and the aging of the immune system. Genes 2021; 12: 1856
    PubMedSearch in Google Scholar
  • 11 Cardus A. et al. SIRT6 protects human endothelial cells from DNA damage, telomere dysfunction, and senescence. Cardiovasc Res 2013; 97: 571-579
    PubMedSearch in Google Scholar
  • 12 Xu H. et al. Sirtuins at the crossroads between mitochondrial quality control and neurodegenerative diseases: structure, regulation, modifications, and modulators. Aging Dis 2023; 14: 794-824
    PubMedSearch in Google Scholar
  • 13 Massudi H. et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS ONE 2012; 7: e42357
    PubMedSearch in Google Scholar
  • 14 Groth B. et al. NAD+ metabolism, metabolic stress, and infection. Front Mol Biosci 2021; 8: 686412
    PubMedSearch in Google Scholar
  • 15 Imai SI. Nicotinamide phosphoribosyltransferase (Nampt): A link between NAD biology, metabolism, and diseases. Curr Pharm Des 2009; 15: 20-28
    PubMedSearch in Google Scholar
  • 16 Peng A. et al. The function of nicotinamide phosphoribosyl transferase (NAMPT) and its role in diseases. Front Mol Biosci 2024; 11: 1480617
    PubMedSearch in Google Scholar
  • 17 Chini CC. et al. NAD and the aging process: Role in life, death and everything in between. Mol Cell Endocrinol 2017; 455: 62-74
    PubMedSearch in Google Scholar
  • 18 Imai S, Yoshino J. The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing. Diabetes Obes Metab 2013; 15: 26-33
    PubMedSearch in Google Scholar
  • 19 Li F, Wu C, Wang G. Targeting NAD metabolism for the therapy of age-related neurodegenerative diseases. Neurosci Bull 2024; 40: 218-240
    PubMedSearch in Google Scholar
  • 20 Amici SA. et al. CD38 is robustly induced in human macrophages and monocytes in inflammatory conditions. Front Immunol 2018; 9: 1593
    CrossrefPubMedSearch in Google Scholar
  • 21 Covarrubias AJ. et al. Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages. Nat Metab 2020; 2: 1265-1283
    PubMedSearch in Google Scholar
  • 22 Chini CC. et al. CD38 ecto-enzyme in immune cells is induced during aging regulating NAD+ and NMN levels. Nat Metab 2020; 2: 1284-1304
    PubMedSearch in Google Scholar
  • 23 Chini C. et al. The NADase CD38 is induced by factors secreted from senescent cells providing a potential link between senescence and age-related cellular NAD+ decline. Biochem Biophys Res Comm 2019; 513: 486-493
    PubMedSearch in Google Scholar
  • 24 Amjad S. et al. Role of NAD+ in regulating cellular and metabolic signaling pathways. Mol Metab 2021; 49: 101195
    PubMedSearch in Google Scholar
  • 25 Gomes AP. et al. Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 2013; 155: 1624-1638
    PubMedSearch in Google Scholar
  • 26 Dehhaghi M. et al. The role of kynurenine pathway and NAD+ metabolism in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Aging Dis 2022; 13: 698-711
    PubMedSearch in Google Scholar
  • 27 Block T, Kuo J. Rationale for nicotinamide adenine dinucleotide (NAD+) metabolome disruption as a pathogenic mechanism of post-acute COVID-19 syndrome. Clin Pathol 2022; 15 2632010X221106986
    Search in Google Scholar
  • 28 Wu J. et al. Sources and implications of NADH/NAD+ redox imbalance in diabetes and its complications. Diabetes Metab Syndr Obes 2016; 9: 145-153
    PubMedSearch in Google Scholar
  • 29 Cortés-Rojo C. et al. Interplay between NADH oxidation by complex I, glutathione redox state and sirtuin-3, and its role in the development of insulin resistance. Biochim Biophys Acta Mol Basis Dis 2020; 1866: 165801
    PubMedSearch in Google Scholar
  • 30 Abdellatif M. et al. NAD+ and vascular dysfunction: from mechanisms to therapeutic opportunities. J Lipid Atheroscler 2022; 11: 111-132
    PubMedSearch in Google Scholar
  • 31 Lin Q. et al. NAD+ and cardiovascular diseases. Clin Chim Acta 2021; 515: 104-110
    PubMedSearch in Google Scholar
  • 32 Migliavacca E. et al. Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities. Nat Commun 2019; 20: 5808
    Search in Google Scholar
  • 33 Gudenschwager C. et al. Directly reprogrammed human neurons to understand age-related energy metabolism impairment and mitochondrial dysfunction in healthy aging and neurodegeneration. Oxid Med Cell Longev 2021; 2021: 5586052
    PubMedSearch in Google Scholar
  • 34 Choi EH. et al. Targeting mitochondrial dysfunction and reactive oxygen species for neurodegenerative disease treatment. Int J Mol Sci 2024; 25: 7952
    PubMedSearch in Google Scholar
  • 35 Lautrup S. et al. NAD+ in brain aging and neurodegenerative disorders. Cell Metab 2019; 30: 630-655
    PubMedSearch in Google Scholar
  • 36 Hosseini L. et al. Protective effects of nicotinamide adenine dinucleotide and related precursors in Alzheimer's disease: a systematic review of preclinical studies. J Mol Neurosci 2021; 71: 1425-1435
    PubMedSearch in Google Scholar
  • 37 Berven H. et al. NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease. Nat Commun 2023; 14: 7793
    CrossrefPubMedSearch in Google Scholar
  • 38 Orr ME. et al. A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. Geroscience 2024; 46: 66-82
    Search in Google Scholar
  • 39 Fang J. et al. NAD+ metabolism-based immunoregulation and therapeutic potential. Cell Biosci 2023; 13: 81
    PubMedSearch in Google Scholar
  • 40 Navarro MN. et al. Nicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing. Br J Pharmacol 2022; 179: 1839-1856
    CrossrefPubMedSearch in Google Scholar
  • 41 Covarrubias AJ. et al. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol 2021; 22: 119-141
    CrossrefPubMedSearch in Google Scholar
  • 42 Makarov MV. et al. The chemistry of the vitamin B3 metabolome. Biochem Soc Trans 2019; 47: 131-147
    PubMedSearch in Google Scholar
  • 43 Freese R, Lysne V. Niacin – a scoping review for Nordic Nutrition Recommendations 2023. Food Nutr Res 2023; 67: 10299
    Search in Google Scholar
  • 44 Wie Z. et al. Caloric restriction, sirtuins, and cardiovascular diseases. Chin Med J 2024; 137: 921-935
    PubMedSearch in Google Scholar
  • 45 Levine DC. et al. NAD+ controls circadian reprogramming through PER2 nuclear translocation to counter aging. Mol Cell 2020; 78: 835-849
    CrossrefPubMedSearch in Google Scholar
  • 46 Reiten OK. et al. Preclinical and clinical evidence of NAD+ precursors in health, disease, and ageing. Mech Ageing Dev 2021; 199: 111567
    PubMedSearch in Google Scholar
  • 47 Canto C. NAD+ precursors: a questionable redundancy. Metabolites 2022; 12: 630
    PubMedSearch in Google Scholar
  • 48 Liu Y. et al. Quantitation of NAD+: why do we need to measure it?. Biochim Biophys Acta Gen Subj 2018; 1862: 2527-2532
    PubMedSearch in Google Scholar
  • 49 Beltrà M. et al. NAD+ repletion with niacin counteracts cancer cachexia. Nat Commun 2023; 14: 1849
    PubMedSearch in Google Scholar